Projects per year
Collaborations and top research areas from the last five years
Projects
- 2 Active
-
Bijlsma M.F.: [NO DATA]
Bijlsma, M., Creemers, A., Ebbing, E., Le Large, T., Lodestijn, S., Steins, A., Tekin, C. & Veenstra, V.
1/06/2016 → …
Project: Research
-
van Laarhoven H.W.M.: Translational research in medical oncology
Anderegg, M., Creemers, A., Ebbing, E., Hartog, I., Klaassen, R., van Kleef, J. J., Kruizinga, R., Le Large, T., Linnekamp, J., Netjes, J., van Rijssen, B., Steins, A., Strijker, M., Veenstra, V., ter Veer, E., van Laarhoven, H., Hidding, J., ter Voert, E. & de Vries, Y.
1/01/2013 → …
Project: Research
-
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease
Mato Prado, M., Puik, J. R., Castellano, L., López-Jiménez, E., Liu, D. S. K., Meijer, L. L., Le Large, T. Y. S., Rees, E., Funel, N., Sivakumar, S., Pereira, S. P., Kazemier, G., Zonderhuis, B. M., Erdmann, J. I., Swijnenburg, R-J., Frilling, A., Jiao, L. R., Stebbing, J., Giovannetti, E., Krell, J., & 1 others , 1 Dec 2023, In: Experimental hematology & oncology. 12, 1, p. 101Research output: Contribution to journal › Article › Academic › peer-review
-
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data
Boyd, L. N. C., Ali, M., Leeflang, M. M. G., Treglia, G., de Vries, R., le Large, T. Y. S., Besselink, M. G., Giovannetti, E., van Laarhoven, H. W. M. & Kazemier, G., 1 Jan 2023, In: EClinicalMedicine. 55, 101747.Research output: Contribution to journal › Article › Academic › peer-review
Open Access12 Citations (Scopus) -
hENT1 as a Predictive Biomarker in PDAC—Letter
Boyd, L. N. C., Ali, M., Puik, J. R., Meijer, L. L., le Large, T. Y. S., van Laarhoven, H. W. M., Giovannetti, E. & Kazemier, G., 1 Aug 2023, In: Clinical Cancer Research. 29, 15, p. 2944 1 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access -
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers
Boyd, L. N. C., Ali, M., Comandatore, A., Garajova, I., Kam, L., Puik, J. R., Fraga Rodrigues, S. M., Meijer, L. L., le Large, T. Y. S., Besselink, M. G., Morelli, L., Frampton, A., van Laarhoven, H. W. M., Giovannetti, E. & Kazemier, G., 1 Aug 2023, In: JAMA Network Open. 6, 8, p. e2331197Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study
Boyd, L. N. C., Nooijen, L. E., Ali, M., Puik, J. R., Moustaquim, J., Fraga Rodrigues, S. M., Broos, R., Belkouz, A., Meijer, L. L., Le Large, T. Y. S., Erdmann, J. I., Heger, M., Van Laarhoven, H. W. M., Roos, E., Kazemier, G., Giovannetti, E., Verheij, J., Klümpen, H-J. & Hooijer, G. K. J., 2023, In: Frontiers in Pharmacology. 14, p. 1274692 1274692.Research output: Contribution to journal › Article › Academic › peer-review
Open Access
Datasets
-
Circulating microRNAs as diagnostic biomarkers for pancreatic cancer
Le Large, T. (Contributor), Meijer, L. L. (Creator), Mato Prado, M. (Contributor), Kazemier, G. (Creator), Frampton, A. E. (Creator) & Giovannetti, E. (Creator), Figshare, 2015
DOI: 10.6084/m9.figshare.1603350, https://figshare.com/articles/Circulating_microRNAs_as_diagnostic_biomarkers_for_pancreatic_cancer/1603350
Dataset
Activities
- 3 Oral presentation
-
Phosphoproteome networks identify focal adhesion kinase as new target in pancreatic ductal adenocarcinoma.
TYS Le Large (Speaker)
Sept 2017Activity: Lecture / Presentation › Oral presentation › Academic
-
Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX in advanced pancreatic ductal adenocarcinoma
LL Meijer (Speaker), C Caparello (Speaker), TYS Le Large (Speaker), BM Zonderhuis (Speaker), F Daams (Speaker), E Giovannetti (Speaker) & G Kazemier (Speaker)
May 2017Activity: Lecture / Presentation › Oral presentation › Academic
-
Plasma microRNAs predict progression in patients with advanced pancreatic ductal adenocarcinoma treated with FOLFIRINOX chemotherapy
LL Meijer (Speaker), C Caparello (Speaker), TYS Le Large (Speaker), G Kazemier (Speaker) & E Giovannetti (Speaker)
Jun 2017Activity: Lecture / Presentation › Oral presentation › Academic